These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24211691)

  • 1. SLC6A3 is a risk factor for Parkinson's disease: a meta-analysis of sixteen years' studies.
    Zhai D; Li S; Zhao Y; Lin Z
    Neurosci Lett; 2014 Apr; 564():99-104. PubMed ID: 24211691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
    Moreau C; Meguig S; Corvol JC; Labreuche J; Vasseur F; Duhamel A; Delval A; Bardyn T; Devedjian JC; Rouaix N; Petyt G; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Azulay JP; Tison F; Destée A; Vidailhet M; Rascol O; Dujardin K; Defebvre L; Bordet R; Sablonnière B; Devos D;
    Brain; 2015 May; 138(Pt 5):1271-83. PubMed ID: 25805645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between the SLC6A3 VNTR 9-repeat allele and alcoholism-a meta-analysis.
    Du Y; Nie Y; Li Y; Wan YJ
    Alcohol Clin Exp Res; 2011 Sep; 35(9):1625-34. PubMed ID: 21554332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease.
    Kelada SN; Costa-Mallen P; Checkoway H; Carlson CS; Weller TS; Swanson PD; Franklin GM; Longstreth WT; Afsharinejad Z; Costa LG
    Pharmacogenet Genomics; 2005 Sep; 15(9):659-68. PubMed ID: 16041244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson's disease.
    Habak C; Noreau A; Nagano-Saito A; Mejía-Constaín B; Degroot C; Strafella AP; Chouinard S; Lafontaine AL; Rouleau GA; Monchi O
    Brain; 2014 Nov; 137(Pt 11):3025-35. PubMed ID: 25212851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5' and 3' region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson's disease risk: a hypothesis-generating study.
    Kelada SN; Checkoway H; Kardia SL; Carlson CS; Costa-Mallen P; Eaton DL; Firestone J; Powers KM; Swanson PD; Franklin GM; Longstreth WT; Weller TS; Afsharinejad Z; Costa LG
    Hum Mol Genet; 2006 Oct; 15(20):3055-62. PubMed ID: 16963468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies.
    Costa A; Riedel M; Müller U; Möller HJ; Ettinger U
    Synapse; 2011 Oct; 65(10):998-1005. PubMed ID: 21404331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC6A3 rs28363170 and rs3836790 variants in Han Chinese patients with sporadic Parkinson's disease.
    Lu Q; Song Z; Deng X; Xiong W; Xu H; Zhang Z; Lu H; Deng H
    Neurosci Lett; 2016 Aug; 629():48-51. PubMed ID: 27353511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic influences of dopamine transport gene on alcohol dependence: a pooled analysis of 13 studies with 2483 cases and 1753 controls.
    Xu M; Lin Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1255-60. PubMed ID: 21078357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 10-Repeat 3'-UTR VNTR Polymorphism in the
    Zeng Q; Ning F; Gu S; Zeng Q; Chen R; Peng L; Zou D; Ma G; Wang Y
    Front Genet; 2021; 12():757601. PubMed ID: 34646314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.
    Michałowska M; Chalimoniuk M; Jówko E; Przybylska I; Langfort J; Toczylowska B; Krygowska-Wajs A; Fiszer U
    Brain Behav; 2020 Mar; 10(3):e01537. PubMed ID: 32022467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter genetic variants and pesticides in Parkinson's disease.
    Ritz BR; Manthripragada AD; Costello S; Lincoln SJ; Farrer MJ; Cockburn M; Bronstein J
    Environ Health Perspect; 2009 Jun; 117(6):964-9. PubMed ID: 19590691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between a 3'UTR VNTR polymorphism of dopamine transporter gene (SLC6A3) and ADHD in a Brazilian sample of adult patients.
    Aparecida da Silva M; Cordeiro Q; Louzã M; Vallada H
    J Atten Disord; 2011 May; 15(4):305-9. PubMed ID: 20332413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's disease.
    Kaplan N; Vituri A; Korczyn AD; Cohen OS; Inzelberg R; Yahalom G; Kozlova E; Milgrom R; Laitman Y; Friedman E; Rosset S; Hassin-Baer S
    J Mol Neurosci; 2014 Jun; 53(2):183-8. PubMed ID: 24633632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic susceptibility to Parkinson's disease among South and North Indians: I. Role of polymorphisms in dopamine receptor and transporter genes and association of DRD4 120-bp duplication marker.
    Juyal RC; Das M; Punia S; Behari M; Nainwal G; Singh S; Swaminath PV; Govindappa ST; Jayaram S; Muthane UB; Thelma BK
    Neurogenetics; 2006 Nov; 7(4):223-9. PubMed ID: 16816977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine transporter gene and Parkinson's disease in a Chinese population.
    Leighton PW; Le Couteur DG; Pang CC; McCann SJ; Chan D; Law LK; Kay R; Pond SM; Woo J
    Neurology; 1997 Dec; 49(6):1577-9. PubMed ID: 9409349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male, but not to female patients.
    Lin JJ; Yueh KC; Chang DC; Chang CY; Yeh YH; Lin SZ
    J Neurol Sci; 2003 May; 209(1-2):87-92. PubMed ID: 12686408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.
    Sieminska A; Buczkowski K; Jassem E; Niedoszytko M; Tkacz E
    BMC Med Genet; 2009 Sep; 10():92. PubMed ID: 19761593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease.
    Dissanayaka NN; Silburn PA; O'Sullivan JD; Mellick GD
    Mov Disord; 2009 Jan; 24(1):111-5. PubMed ID: 18973248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between VNTR polymorphism of dopamine transporter gene (SLC6A3) and schizophrenia in a Brazilian sample.
    Cordeiro Q; Talkowski M; Wood J; Ikenaga E; Vallada H
    Arq Neuropsiquiatr; 2004 Dec; 62(4):973-6. PubMed ID: 15608954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.